| Iguratimod in Kidney Transplant Recipients (NCT02839941) | The First Affiliated Hospital with Nanjing Medical University | 2016-08-01 |
| Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation (NCT03134625) | Seoul National University Hospital | 2016-06-28 |
| Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus (NCT02576366) | Universitaire Ziekenhuizen KU Leuven | 2016-06-01 |
| Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients (NCT02808065) | Seoul National University Hospital | 2016-05-01 |
| Smart Phone Medication Adherence Saves Kidneys--SMASK (NCT02827695) | Medical University of South Carolina | 2016-05-01 |
| IVIg to Treat BK Viremia in Kidney Transplant Recipients (NCT02659891) | Massachusetts General Hospital | 2016-05-01 |
| Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography (NCT02775838) | University Hospital Erlangen | 2016-04-01 |
| Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients (NCT03425071) | University of Sao Paulo General Hospital | 2016-03-08 |
| Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients (NCT02644915) | Xijing Hospital | 2016-03-01 |
| The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration (NCT02707822) | National Taiwan University Hospital | 2016-01-01 |
| The Use of the Social Networking to Promote Educational and Consultative Actions Among Kidney Transplanted Adolescents. (NCT03214965) | Instituto de Cardiologia do Rio Grande do Sul | 2016-01-01 |
| An US Mathematical Model in Predicting Renal Transplant Rejection (NCT03045731) | Shanghai Zhongshan Hospital | 2016-01-01 |
| Regimen Optimization Study (NCT02137239) | Bristol-Myers Squibb | 2015-12-31 |
| Pre-formed Alloreactivity in Renal Transplant Recipients (NCT02633826) | Martina Sester | 2015-11-01 |
| Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant. (NCT02563366) | First Affiliated Hospital, Sun Yat-Sen University | 2015-11-01 |
| Effect of BM-MSCs on Chronic AMR After Kidney Transplantation (NCT02563340) | First Affiliated Hospital, Sun Yat-Sen University | 2015-11-01 |
| Effect of BM-MSCs in DCD Kidney Transplantation (NCT02561767) | First Affiliated Hospital, Sun Yat-Sen University | 2015-10-01 |
| Bela 8 Week Dosing (NCT02560558) | Emory University | 2015-09-01 |
| Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation (NCT02417870) | Anil K. Chandraker, MD | 2015-09-01 |
| Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function (NCT02568696) | Helsinki University Central Hospital | 2015-06-01 |
| A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients (NCT02444143) | University of Illinois at Chicago | 2015-05-01 |
| Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients (NCT03173820) | Khon Kaen University | 2015-04-30 |
| Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients? (NCT02610946) | Stanford University | 2015-04-01 |
| Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients (NCT02555787) | Astellas Pharma Europe Ltd. | 2015-03-05 |
| BIOMARGIN European, Ambispective Cohort of Adult and Paediatric Renal Transplant Patients (NCT02832661) | University Hospital, Limoges | 2015-03-01 |
| Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation (NCT03623217) | Astellas Pharma Korea, Inc. | 2015-02-24 |
| CCFZ533X2201 - PoC Study in de Novo Renal Transplantation (NCT02217410) | Novartis Pharmaceuticals | 2015-02-05 |
| A Randomized Control Trial of Antibiotic Treatment Duration For Asymptomatic Bacteriuria After Kidney Transplantation (NCT02575495) | Mahidol University | 2015-02-01 |
| Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation (NCT02351427) | Asan Medical Center | 2015-02-01 |
| Whole-body Vibration Physiotherapy in Kidney Transplantation (NCT02345577) | Insel Gruppe AG, University Hospital Bern | 2014-12-16 |
| Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Interest and Feasibility. (NCT02830191) | University Hospital, Caen | 2014-11-01 |
| Pre-emptive Kidney Transplantation Quality of Life (NCT02154815) | Nantes University Hospital | 2014-09-01 |
| iChoose Decision Kidney Aid for End-Stage Renal Disease Patients (NCT02235571) | Emory University | 2014-09-01 |
| Bone Mass and Strength After Kidney Transplantation (NCT02224144) | Columbia University | 2014-08-18 |
| Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant (NCT02208791) | University of Sao Paulo General Hospital | 2014-07-01 |
| Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation (NCT02161237) | Astellas Pharma Inc | 2014-06-26 |
| The Effects of Pre-operative Anxiety on Anesthetic Recovery and Post-operative Pain in Donor Nephrectomy (NCT03131258) | Ege University | 2014-06-01 |
| ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF (NCT02056938) | Nantes University Hospital | 2014-06-01 |
| The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria (NCT01871753) | Erasme University Hospital | 2014-04-01 |
| Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT) (NCT02081729) | Asan Medical Center | 2014-03-01 |
| Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring (NCT02058875) | University of Saskatchewan | 2014-02-01 |
| Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant (NCT02550639) | ORIOL BESTARD | 2014-02-01 |
| BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (NCT02029638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-07 |
| Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation (NCT02782416) | National Taiwan University Hospital | 2014-01-01 |
| Impact of Arterial Stiffness and Central Aortic Blood Pressure on Kidney Transplant Outcomes (NCT02000869) | Louisiana State University Health Sciences Center Shreveport | 2014-01-01 |
| Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients (NCT02062892) | University of Colorado, Denver | 2013-12-01 |
| Efficacy of Belatacept in Reducing DSA (NCT02078193) | East Carolina University | 2013-11-01 |
| CEUS in Kidney and Pancreas Transplantation (NCT02104024) | University of Manchester | 2013-10-01 |
| Bile Acids and Incretins in Pancreas Kidney Transplant Patients (NCT02234349) | Hospices Civils de Lyon | 2013-09-05 |
| ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients (NCT01905514) | Seoul National University Hospital | 2013-09-01 |
| Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1 (NCT02147210) | University Hospital, Toulouse | 2013-09-01 |
| Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression (NCT01875224) | University of Arizona | 2013-08-01 |
| Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients (NCT02083042) | Lophius Biosciences GmbH | 2013-08-01 |
| Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen (NCT01856257) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-07-01 |
| NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients (NCT01771705) | University of California, San Francisco | 2013-05-02 |
| Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis (NCT01860183) | Clinical Hospital Merkur | 2013-05-01 |
| A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based (NCT01820572) | Bristol-Myers Squibb | 2013-03-27 |
| A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients (NCT01780844) | Astellas Pharma Global Development, Inc. | 2013-03-05 |
| EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety (NCT01834768) | CHU de Reims | 2013-02-01 |
| Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus (NCT02644395) | Erasmus Medical Center | 2013-01-18 |
| Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients (NCT01842269) | Chong Kun Dang Pharmaceutical | 2013-01-01 |
| Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients (NCT01781871) | Helsinki University Central Hospital | 2013-01-01 |
| 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients (NCT01843348) | Novartis Pharmaceuticals | 2012-12-27 |
| Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation (NCT02459470) | Samsung Medical Center | 2012-12-01 |
| A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients (NCT01649388) | Talaris Therapeutics Inc. | 2012-10-15 |
| Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk (NCT01702207) | University of Saskatchewan | 2012-10-01 |
| The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients (NCT01699360) | Central South University | 2012-09-01 |
| Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors (NCT01653041) | Hospital do Rim e Hipertensão | 2012-08-01 |
| Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation (NCT01622881) | Severance Hospital | 2012-06-01 |
| Effectiveness of an APN-led Self-management Program in Patients in the First Year After Renal Transplantation (NCT02282124) | University of Zurich | 2012-05-01 |
| A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time (NCT01614665) | Astellas Pharma Europe Ltd. | 2012-04-03 |
| Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China (NCT01796639) | Novartis | 2012-04-01 |
| The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea (NCT02459977) | Asan Medical Center | 2012-04-01 |
| Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (NCT01471223) | Bristol-Myers Squibb | 2012-03-31 |
| A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India (NCT02432053) | Astellas Pharma Inc | 2012-03-01 |
| Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant (NCT01386359) | Bristol-Myers Squibb | 2012-02-29 |
| Intervention to Improve Adherence in Teen Kidney Transplant (NCT01356277) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2012-02-01 |
| Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation (NCT01897961) | Centre Hospitalier Universitaire de Nice | 2012-01-10 |
| Protocol DIVAT-Uro (NCT01280708) | Nantes University Hospital | 2012-01-02 |
| Left Ventricular Diastolic Dysfunction in Kidney Recipients (NCT02322567) | Severance Hospital | 2012-01-01 |
| A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients (NCT01442337) | Astellas Pharma Inc | 2011-12-01 |
| Everolimus in de Novo Kidney Transplant Recipients (NCT01410448) | Novartis Pharmaceuticals | 2011-11-01 |
| Kidney Allograft Recipients in England - an Observational Cohort Study (NCT01798524) | University Hospital Birmingham NHS Foundation Trust | 2011-11-01 |
| Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients (NCT01656343) | Bristol-Myers Squibb | 2011-10-31 |
| Alefacept in Kidney Transplant Recipients (NCT01433770) | University Hospitals Cleveland Medical Center | 2011-10-01 |
| Study of Subclinical Viral Infection (NCT01615341) | Seattle Children's Hospital | 2011-10-01 |
| An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil (NCT01672957) | Hoffmann-La Roche | 2011-09-01 |
| Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation (NCT01436305) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation (NCT01655563) | The Hospital for Sick Children | 2011-09-01 |
| Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients (NCT01375127) | Pfizer | 2011-08-01 |
| The Effect of Remote Postconditioning on Graft Function in Patients Undergoing Living-related Kidney Transplantation (NCT01363687) | Samsung Medical Center | 2011-08-01 |
| Study Investigating Rapamune For Post-Marketing Surveillance (NCT00484094) | Pfizer | 2011-07-01 |
| Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients (NCT01476488) | Seoul National University Hospital | 2011-07-01 |
| A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients (NCT01371344) | Astellas Pharma Europe Ltd. | 2011-06-24 |
| A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation (NCT01371331) | Astellas Pharma Europe Ltd. | 2011-06-09 |
| Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function (NCT01395719) | University of Aarhus | 2011-06-01 |
| Prediction of Chronic Allograft Nephropathy (NCT01380847) | Assistance Publique - Hôpitaux de Paris | 2011-06-01 |
| Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf® (NCT01294020) | Astellas Pharma Europe Ltd. | 2011-05-25 |
| Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen (NCT01560572) | University Medical Center Groningen | 2011-04-01 |
| A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients (NCT01742676) | Astellas Pharma Korea, Inc. | 2011-04-01 |